Get started
ELI LILLY & COMPANYELI LILLY & COMPANYELI LILLY & COMPANY

ELI LILLY & COMPANY

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

1LLY chart


Full chart

Key facts today

Redburn Atlantic raised its price target on Eli Lilly to $700 from $640, keeping a neutral rating. Analysts report an average outperform rating, with price targets between $580 and $1,250.
Eli Lilly's weight-loss drug Zepbound competes in the GLP-1 market against Novo Nordisk's Wegovy, as firms strive to create oral versions of these treatments.
Eli Lilly's diabetes drug Mounjaro and weight-loss drug Zepbound were removed from the FDA's shortage list, with Mounjaro having been on the list since late 2022 and Zepbound since April.
Analyze the impactAnalyze the impact

1LLY upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪717.58 B‬EUR
Dividend yield (indicated)
0.63%
Price to earnings Ratio (TTM)
90.3
Basic EPS (TTM)
8.2EUR
Net income (FY)
‪4.75 B‬EUR
Revenue (FY)
‪30.92 B‬EUR
Shares float
‪850.72 M‬
Beta (1Y)
0.85

Employees


Employees (FY)
‪43 K‬
Change (1Y)
‪+4 K‬ +10.26%
Revenue / Employee (1Y)
‪793.58 K‬EUR
Net income / Employee (1Y)
‪121.87 K‬EUR

About Eli Lilly and Company


Sector
Health Technology
CEO
David A. Ricks
Headquarters
Indianapolis
Website
lilly.com
Founded
1876
FIGI
BBG01K3Y1TZ3
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas



See all ideas 

1LLY news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

1LLY highest yielding bonds


US532457AM0
ELI LILLY 2025
Yield to maturity
6.07%
Maturity date
Jun 1, 2025
LLY4099975
Eli Lilly and Company 4.65% 15-JUN-2044
Yield to maturity
5.39%
Maturity date
Jun 15, 2044
LLY5871804
Eli Lilly and Company 5.2% 14-AUG-2064
Yield to maturity
5.32%
Maturity date
Aug 14, 2064
LLY5750032
Eli Lilly and Company 5.1% 09-FEB-2064
Yield to maturity
5.30%
Maturity date
Feb 9, 2064
US532457BS6
ELI LILLY 19/39
Yield to maturity
5.28%
Maturity date
Mar 15, 2039
LLY.GG
Eli Lilly and Company 6.77% 01-JAN-2036
Yield to maturity
5.24%
Maturity date
Jan 1, 2036
LLY5547404
Eli Lilly and Company 4.875% 27-FEB-2053
Yield to maturity
5.23%
Maturity date
Feb 27, 2053
LLY5547405
Eli Lilly and Company 4.95% 27-FEB-2063
Yield to maturity
5.22%
Maturity date
Feb 27, 2063
LLY5750031
Eli Lilly and Company 5.0% 09-FEB-2054
Yield to maturity
5.22%
Maturity date
Feb 9, 2054
LLY5871803
Eli Lilly and Company 5.05% 14-AUG-2054
Yield to maturity
5.21%
Maturity date
Aug 14, 2054
US532457BT4
ELI LILLY 19/49
Yield to maturity
5.14%
Maturity date
Mar 15, 2049

Explore more bonds 

Sparks


Curated watchlists where 1LLY is featured.

See all sparks 

Frequently Asked Questions


The current price of 1LLY is 740.4 EUR — it has decreased by −2.27% in the past 24 hours. Watch ELI LILLY & COMPANY stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange ELI LILLY & COMPANY stocks are traded under the ticker 1LLY.
1LLY stock has fallen by −10.54% compared to the previous week, the month change is a −7.48% fall, over the last year ELI LILLY & COMPANY has showed a 32.81% increase.
We've gathered analysts' opinions on ELI LILLY & COMPANY future price: according to them, 1LLY price has a max estimate of 1,149.40 EUR and a min estimate of 643.67 EUR. Watch 1LLY chart and read a more detailed ELI LILLY & COMPANY stock forecast: see what analysts think of ELI LILLY & COMPANY and suggest that you do with its stocks.
1LLY reached its all-time high on Jul 15, 2024 with the price of 886.1 EUR, and its all-time low was 516.0 EUR and was reached on Dec 22, 2023. View more price dynamics on 1LLY chart.
See other stocks reaching their highest and lowest prices.
1LLY stock is 0.55% volatile and has beta coefficient of 0.85. Track ELI LILLY & COMPANY stock price on the chart and check out the list of the most volatile stocks — is ELI LILLY & COMPANY there?
Today ELI LILLY & COMPANY has the market capitalization of ‪714.86 B‬, it has decreased by −5.26% over the last week.
Yes, you can track ELI LILLY & COMPANY financials in yearly and quarterly reports right on TradingView.
ELI LILLY & COMPANY is going to release the next earnings report on Jan 30, 2025. Keep track of upcoming events with our Earnings Calendar.
1LLY earnings for the last quarter are 1.06 EUR per share, whereas the estimation was 1.28 EUR resulting in a −16.97% surprise. The estimated earnings for the next quarter are 5.02 EUR per share. See more details about ELI LILLY & COMPANY earnings.
ELI LILLY & COMPANY revenue for the last quarter amounts to ‪10.27 B‬ EUR, despite the estimated figure of ‪10.87 B‬ EUR. In the next quarter, revenue is expected to reach ‪12.89 B‬ EUR.
1LLY net income for the last quarter is ‪871.47 M‬ EUR, while the quarter before that showed ‪2.77 B‬ EUR of net income which accounts for −68.54% change. Track more ELI LILLY & COMPANY financial stats to get the full picture.
Yes, 1LLY dividends are paid quarterly. The last dividend per share was 1.18 EUR. As of today, Dividend Yield (TTM)% is 0.61%. Tracking ELI LILLY & COMPANY dividends might help you take more informed decisions.
ELI LILLY & COMPANY dividend yield was 0.78% in 2023, and payout ratio reached 77.91%. The year before the numbers were 1.07% and 56.79% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 5, 2024, the company has ‪43.00 K‬ employees. See our rating of the largest employees — is ELI LILLY & COMPANY on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ELI LILLY & COMPANY EBITDA is ‪14.47 B‬ EUR, and current EBITDA margin is 34.73%. See more stats in ELI LILLY & COMPANY financial statements.
Like other stocks, 1LLY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ELI LILLY & COMPANY stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ELI LILLY & COMPANY technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ELI LILLY & COMPANY stock shows the sell signal. See more of ELI LILLY & COMPANY technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.